Fentanyl (opioids) and Respiratory depression: is the FAERS signal real?
Fentanyl (opioids) ↔ Respiratory depression
Fentanyl, a potent synthetic opioid, suppresses the brainstem's drive to breathe, so respiratory depression is the direct, dose-related consequence of opioid action and the mechanism behind most opioid fatalities. The risk is amplified by other sedatives (benzodiazepines, alcohol, gabapentinoids) and is why the drug carries boxed warnings and why naloxone is used to reverse it. The 920 co-reports (PRR 17.3) reflect both the real effect and the drug's use in anaesthesia, cancer pain, and (illicitly) as a cause of overdose.
Regulatory basis: fentanyl prescribing information (boxed warning for respiratory depression; naloxone reversal). Established opioid respiratory-depression literature.
| Bradford Hill viewpoint | Status | Note |
|---|---|---|
| Temporality (necessary) | met | Breathing slows during opioid effect and is reversed by naloxone or withdrawal |
| Strength | met | PRR 17 on a moderate co-report count |
| Consistency | met | Reproduced across opioids and in anaesthesia practice |
| Specificity | met | An opioid-class effect, most dangerous with potent agents |
| Biological gradient | partial | Strongly dose-related and worse with sedatives |
| Plausibility | met | Mu-opioid-receptor suppression of the brainstem respiratory centre is the mechanism |
| Coherence | met | Coheres with the boxed warning and naloxone reversal |
| Experiment | partial | Dechallenge (naloxone) reliably reverses it; no randomized trial |
| Analogy | met | Analogous to respiratory depression with morphine, methadone, and other opioids |
This page's own qualitative read, not an automated/citation-gated assessment.